Zelluna ASA: Invitation to Second Quarter 2025 results webcast presentation

14 Aug 2025 12:00 CEST

Oslo, Norway, 14 August 2025 - Zelluna (OSE: ZLNA), a company pioneering
allogeneic 'off the shelf' T Cell Receptor based Natural Killer (TCR-NK) cells
for the treatment of cancer, invites you to a webcast presentation of its second
quarter 2025 results, on Wednesday, August 20, 2025.

The presentation can be followed as a live webcast accessed through a link on
www.zelluna.com at 09:00 CET on Wednesday, August 20, 2025. The webcast
presentation will be available on the Zelluna website, and it will be possible
to post questions during the presentation through the webcast.

The report and presentation will be available on the company website from 07:00
CET the same day.

For further information, please see www.zelluna.com or contact:

For further information, please contact:

Namir Hassan, CEO, Zelluna ASA
Email: namir.hassan@zelluna.com
(https://www.globenewswire.com/Tracker?data=Z8lLmV-
B1LwB9B24FA19vFGXbMF1uWuib96CE8rRZizu90Na0VH2EMuvz0ZT8R_M3cGZvcz7cwsWR7BQXKOGGup
zjLAZA3udqBHb-dOQPqaJliih1_RADUlCCR7Hs9ov)
Phone: +44 7720 687608

Hans Vassgård Eid, CFO, Zelluna ASA
Email: hans.eid@zelluna.com
(https://www.globenewswire.com/Tracker?data=xw_BegYpiBk6hexlBFgOsk7tj2DC2GZ9wD-
xUL0RvSOAFKyBsXJCyN1-
yeYF_y4PiN7qNCFrqSFIFzf4Oy78pFiEzLGlsgS23tV0HELOjUoSe5eLjAVVxGWn_gS6AJdD)
Phone: +47 482 48632

More information:
Access the news on Oslo Bors NewsWeb site